Summit Therapeutics
SMMT
#1526
Rank
โ‚ฌ11.68 B
Marketcap
15,70ย โ‚ฌ
Share price
-2.66%
Change (1 day)
-11.13%
Change (1 year)

Revenue for Summit Therapeutics (SMMT)

Revenue in 2025 (TTM): N/A

In 2024 the company made a revenue of N/A a decrease over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Summit Therapeutics from 2017 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) N/A
2024 N/A
2023 N/A-100%
2022 โ‚ฌ0.65 M-58.85%
2021 โ‚ฌ1.59 M
2019 โ‚ฌ1.29 M-98.08%
2018 โ‚ฌ67.3 M226.26%
2017 โ‚ฌ20.62 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Sarepta Therapeutics
SRPT
โ‚ฌ2.06 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
โ‚ฌ0.31 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Coherus BioSciences
CHRS
โ‚ฌ71.63 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA